Retention in care among young black and Latino men who have sex with men in the district of Columbia, 2005-2009
Methods: Data were analyzed from DC's HIV surveillance system for HIV-infected YMSM ages 13-29. We combined demographic and clinical variables with social data from the U.S. American Community Survey by census tracts. Frequencies and prevalence ratios were calculated (PR, 95% CI).
Results: From 2005-2009, 575 YMSM were living with HIV infection in DC. Among 465 YMSM of color with HIV infection, 412 (89%) were Black and 53 (11%) were Latino; 406 (87%) had census tract data available and were included in analyses. Of the 367 YMSM linked to care, 220 (59.9%) were retained. Compared with those not retained, retained YMSM of color were more likely to have been diagnosed between ages 13-18 years (1.61, 1.10-2.35) and to have achieved viral suppression (1.57, 1.04-2.37), and less likely to have progressed to AIDS (0.75, 0.36-0.83).
Conclusions: Retention in HIV care is suboptimal for YMSM of color in DC. However, retention is significantly associated with clinical benefit and may reduce risk of ongoing HIV transmission. To improve outcomes and reduce disparities, increased retention efforts are warranted for HIV-positive YMSM of color in DC.
Provision of health care to the public
Public health or related research
Describe the difference in demographic characteristics and health outcomes for HIV positive Black and Latino young men who have sex with men in the District of Columbia who are retained in care versus those who are not retained.
Keyword(s): HIV/AIDS, Treatment
Qualified on the content I am responsible for because: I have conducted multiple studies focusing on health disparities and HIV. My research focuses on the study of social determinants of health that underlie HIV-related health disparities in communities of color.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.